Jason Gardner files SEC Form 4 disclosures for Magenta Therapeutics, Inc.. They have made 6 open-market trades across 1 company since 2018, most recently 2022-11-30.
CIK 0001741286
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2018, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MGTA | 292,872 | $3.3M |
Shares reported on the most recent Form 4, priced at the 2022-12-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MGTA | SELL | 2021-09-16 | 2021-09-20 | $6.73 | $193K | -1.6% | -11.5% | -31.6% |
| MGTA | SELL | 2020-01-10 | 2020-01-10 | $15.25 | $171K | -10.4% | -20.1% | -54.0% |
| MGTA | SELL · 10b5-1 | 2020-01-02 | 2020-01-03 | $15.10 | $42K | -3.4% | -17.9% | -55.6% |
| MGTA | SELL · 10b5-1 | 2019-12-23 | 2019-12-23 | $15.10 | $44K | -7.4% | -12.3% | -61.1% |
| MGTA | SELL | 2019-12-20 | 2019-12-20 | $15.16 | $2.3M | +0.2% | -4.5% | -54.5% |
| MGTA | SELL | 2019-12-10 | 2019-12-13 | $15.10 | $133K | +21.8% | +7.2% | -36.0% |
| MGTA | SELL | 2019-06-20 | 2019-06-24 | $15.11 | $398K | -8.2% | -14.3% | -25.2% |
| MGTA | BUY | 2018-06-25 | 2018-06-27 | $15.00 | $6K | -10.7% | -0.9% | -16.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.